CM
PRVA icon

Castleark Management’s Privia Health PRVA Stock Holding History

Castleark Management’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-146,645
Closed -$3.33M – 316
2022
Q4 		$3.33M Sell
146,645
-23,660
-14% -$659K 0.17% 128
2022
Q3 		$5.8M Buy
+170,305
New +$6.3M 0.32% 69

Other funds holding PRVA

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Castleark Management's PRVA Position: Q1 2023 in Review

Castleark Management sold out of Privia Health (PRVA) in Q1 2023, closing a stake of 146,645 shares — an estimated $3.33M sold.

Castleark Management first reported a position in PRVA in Q3 2022 and held it in 2 quarters. The position peaked at $5.8M in Q3 2022. 191 funds tracked by Wall St. Rank hold PRVA as of Q1 2023.

  • Castleark Management reported no remaining Privia Health position as of Q1 2023 after selling out during the quarter.
  • Castleark Management sold 146,645 Privia Health shares in Q1 2023, an estimated $3.33M.
  • Castleark Management first reported a position in Privia Health in Q3 2022 and held it in 2 quarters.
  • Castleark Management's Privia Health position peaked at $5.8M in Q3 2022.
  • 191 funds tracked by Wall St. Rank held Privia Health as of Q1 2023.

Based on Castleark Management's 13F filing for Q1 2023, filed 16 May 2023.